cresyl violet has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bywood, PT; Johnson, SM | 1 |
| Barnum, CJ; Bhide, N; Bishop, C; Dupre, KB; Eskow Jaunarajs, KL; Lindenbach, D; Ostock, CY | 1 |
2 other study(ies) available for cresyl violet and oxidopamine
| Article | Year |
|---|---|
Dendrite loss is a characteristic early indicator of toxin-induced neurodegeneration in rat midbrain slices.
Topics: Animals; Benzoxazines; Biomarkers; Cell Death; Coloring Agents; Dendrites; Immunohistochemistry; Male; Microtubule-Associated Proteins; Nerve Degeneration; Neurotoxins; Organ Culture Techniques; Oxazines; Oxidopamine; Poisons; Potassium Cyanide; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2000 |
Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat.
Topics: Adrenergic beta-Antagonists; Animals; Antiparkinson Agents; Benzoxazines; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Levodopa; Male; Medial Forebrain Bundle; Molecular Targeted Therapy; Motor Activity; Oxazines; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Time Factors | 2011 |